The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Koselugo (selumetinib sulfate)
Australian Public Assessment Report
Device/Product Name
Koselugo
Active ingredients
Selumetinib sulfate
AusPAR Date
Published
Submission Number
PM-2020-05290-1
Submission Type
New chemical entity
Decision
Approved